Table 2.
Clinical Parameters | Cases | IFIT2 Expression Level | χ2 | P-value | |
---|---|---|---|---|---|
Low(H-score <140) | High(H-score ≥140) | ||||
Gender | |||||
Male | 74 | 51 | 23 | 0.066 | 0.797 |
Female | 4 | 3 | 1 | ||
Age (years) | |||||
≥60 | 49 | 33 | 16 | 0.074 | 0.786 |
<60 | 27 | 19 | 8 | ||
Tumor diameter (cm) | |||||
≥4.5 | 45 | 31 | 14 | 0.006 | 0.939 |
<4.5 | 33 | 23 | 10 | ||
Tumor stage | |||||
T1~T2 | 56 | 39 | 17 | 0.016 | 0.900 |
T3~T4 | 22 | 15 | 7 | ||
Lymph node metastasis* | |||||
Yes | 20 | 14 | 6 | 0.013 | 0.908 |
No | 42 | 30 | 12 | ||
TNM stage | |||||
I~II | 51 | 37 | 14 | 0.762 | 0.383 |
III~IV | 27 | 17 | 10 | ||
Distant metastasis | |||||
Yes | 1 | 0 | 1 | 2.279 | 0.131 |
No | 77 | 54 | 23 |
Note: *There were 16 patients’ lymph node metastasis that could not be assessed.
Abbreviation: IFIT2, interferon-induced proteins with tetratricopeptide repeats 2.